Geron Corp (GERN) – Hot FDA News
-
Geron Corp (GERN) Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat
-
Geron Corp (GERN) climbs 56% after announcing IMerge Phase 3 trial met its primary efficacy endpoint
-
-
-
-
-
-
-
Back to GERN Stock Lookup